Whittemore Tingley - 16 May 2025 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Medical Officer
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol
TNYA
Transactions as of
16 May 2025
Net transactions value
-$1,300
Form type
4
Filing time
16 May 2025, 19:07:25 UTC
Previous filing
10 Mar 2025
Next filing
18 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tingley Whittemore Chief Medical Officer C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact 16 May 2025 0001868494

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Sale $1,300 -2,937 -1.7% $0.4427 171,856 16 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
F2 Includes 107,507 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.